Also found in: Dictionary, Financial, Acronyms, Wikipedia.


The study of drug-related adverse effects carried out by pharmaceutical industries to suggest warnings or recommendations for product withdrawal.


(1) A state of heightened awareness, monitoring and reporting of potentially adverse pharmacologic events.
(2) The branch of pharmacology focused on detecting, assessing, understanding and preventing long- and short-term adverse effects of medicines.


(făr″mă-kō-vĭj′ĭ-lĭns) [″ + ″]
The analysis, detection, and prevention of adverse effects caused by medications.


n the monitoring of adverse effects of drugs and herbal remedies as they are used in the population. Also called
postmarketing surveillance.
References in periodicals archive ?
The primary barriers in the market include high risk associated with securing data in case of pharmacovigilance outsourcing and lack of availability of skilled workforce specialising in drug monitoring.
Shri Nadda stated that India is committed to ensuring patient safety in the country and to building strong working relations with other countries with respect to healthcare system, including pharmacovigilance system.
While these pharmacovigilance programmes generate potentially useful information, there is little collaboration between programmes, even where the same approach, medicines and patient populations were targeted.
Singh said the Central government has initiated a well-structured and highly participative National Pharmacovigilance Programme with the Central Drugs Standard Control Organisation.
These companies, such as Quintiles, Covance, and MDS Pharma Services, are well suited to step up and address pharmacovigilance.
When it comes to pharmacovigilance, hospitals are alerted straight away about a drug issue and action is taken in-house.
Delivery of sustainable training in key aspects of pharmacovigilance and creating a friendly, continuing network for problem-solving
The global market for pharmacovigilance services is segmented based on type of clinical trial phases, service providers and methods used in drug safety reporting.
Les participants a cette journee d'etude ont discute de differents sujets lies a la thematique de la pharmacovigilance.
Today's pharmacovigilance systems are still built upon adverse event reporting, with more than 50% of the resources in a typical drug safety organization being dedicated to this activity alone.
the truly global provider of strategic and outsourced services for clinical safety, pharmacovigilance, medical affairs, and regulatory operations, announced today that it has updated and enhanced its website.

Full browser ?